These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11457546)

  • 1. Cost-effectiveness of influenza vaccination in high-risk children in Argentina.
    Dayan GH; Nguyen VH; Debbag R; Gómez R; Wood SC
    Vaccine; 2001 Jul; 19(30):4204-13. PubMed ID: 11457546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health and economic benefits of new pediatric influenza vaccination programs in Argentina.
    Giglio N; Gentile A; Lees L; Micone P; Armoni J; Reygrobellet C; Crépey P
    Hum Vaccin Immunother; 2012 Mar; 8(3):312-22. PubMed ID: 22330959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.
    Nichol KL
    Vaccine; 2011 Oct; 29(43):7554-8. PubMed ID: 21820477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.
    Nichol KL
    Arch Intern Med; 2001 Mar; 161(5):749-59. PubMed ID: 11231710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of influenza vaccination in preschool children.
    Cohen GM; Nettleman MD
    Pediatrics; 2000 Nov; 106(5):973-6. PubMed ID: 11061762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    Peasah SK; Meltzer MI; Vu M; Moulia DL; Bridges CB
    PLoS One; 2019; 14(4):e0213499. PubMed ID: 31034485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential cost savings attributable to influenza vaccination of school-aged children.
    White T; Lavoie S; Nettleman MD
    Pediatrics; 1999 Jun; 103(6):e73. PubMed ID: 10353970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.
    Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M
    BMC Health Serv Res; 2015 Nov; 15():511. PubMed ID: 26573461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.
    Prosser LA; O'Brien MA; Molinari NA; Hohman KH; Nichol KL; Messonnier ML; Lieu TA
    Pharmacoeconomics; 2008; 26(2):163-78. PubMed ID: 18198935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.
    Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL
    PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
    Yang MC; Tan EC; Su JJ
    Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.
    Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K
    JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children.
    Luce BR; Zangwill KM; Palmer CS; Mendelman PM; Yan L; Wolff MC; Cho I; Marcy SM; Iacuzio D; Belshe RB
    Pediatrics; 2001 Aug; 108(2):E24. PubMed ID: 11483834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
    Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
    Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study.
    Pisu M; Meltzer MI; Hurwitz ES; Haber M
    Pharmacoeconomics; 2005; 23(1):55-67. PubMed ID: 15693728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.
    Gatwood J; Meltzer MI; Messonnier M; Ortega-Sanchez IR; Balkrishnan R; Prosser LA
    Drugs; 2012 Jan; 72(1):35-48. PubMed ID: 22191794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.
    Wongsurakiat P; Lertakyamanee J; Maranetra KN; Jongriratanakul S; Sangkaew S
    J Med Assoc Thai; 2003 Jun; 86(6):497-508. PubMed ID: 12924797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
    Imai C; Toizumi M; Hall L; Lambert S; Halton K; Merollini K
    PLoS One; 2018; 13(6):e0198685. PubMed ID: 29879206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.